Literature DB >> 22761117

Surgical correction of hypertrophic obstructive cardiomyopathy in a patient with severe hypertrophy and septal myocardial fibrosis.

Konstantin Valentinovitch Borisov1.   

Abstract

In patients with hypertrophic cardiomyopathy, myocardial fibrosis is an independent predictor of an adverse outcome. A new technique of hypertrophic obstructive cardiomyopathy (HOCM) surgical correction in patients with severe hypertrophy and septal myocardial fibrosis has been proposed. This approach avoids mechanical damage to the heart conduction system, and for the surgeon it improves visual inspection of the area to be resected. We present a case report of a 33-year old female patient with biventricular obstruction, extreme hypertrophy, septal myocardial fibrosis and episodes of ventricular tachycardia who underwent surgical correction according to this novel procedure. The advantage of the approach is an effective surgical treatment of HOCM in patients with severe hypertrophy and septal myocardial fibrosis who cannot be treated with the current surgical techniques.

Entities:  

Mesh:

Year:  2012        PMID: 22761117      PMCID: PMC3445374          DOI: 10.1093/icvts/ivs289

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  5 in total

1.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy.

Authors:  Rory O'Hanlon; Agata Grasso; Michael Roughton; James C Moon; Susan Clark; Ricardo Wage; Jessica Webb; Meghana Kulkarni; Dana Dawson; Leena Sulaibeekh; Badri Chandrasekaran; Chiara Bucciarelli-Ducci; Ferdinando Pasquale; Martin R Cowie; William J McKenna; Mary N Sheppard; Perry M Elliott; Dudley J Pennell; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

2.  Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease.

Authors:  A M Varnava; P M Elliott; C Baboonian; F Davison; M J Davies; W J McKenna
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

3.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy.

Authors:  Oliver Bruder; Anja Wagner; Christoph J Jensen; Steffen Schneider; Peter Ong; Eva-Maria Kispert; Kai Nassenstein; Thomas Schlosser; Georg V Sabin; Udo Sechtem; Heiko Mahrholdt
Journal:  J Am Coll Cardiol       Date:  2010-06-25       Impact factor: 24.094

4.  Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.

Authors:  G Lin; R A Nishimura; B J Gersh; D Phil; S R Ommen; M J Ackerman; P A Brady
Journal:  Heart       Date:  2009-03-11       Impact factor: 5.994

5.  Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae.

Authors:  Kenji Minakata; Joseph A Dearani; Rick A Nishimura; Barry J Maron; Gordon K Danielson
Journal:  J Thorac Cardiovasc Surg       Date:  2004-02       Impact factor: 5.209

  5 in total
  1 in total

1.  Right ventricle myectomy.

Authors:  Konstantin V Borisov
Journal:  Ann Cardiothorac Surg       Date:  2017-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.